Sanara Medtech Inc
NASDAQ:SMTI
Sanara Medtech Inc
NASDAQ:SMTI
Price:
31.25 USD
-3.64%
Updated:
Apr 30, 2024
Sanara Medtech Inc
Operating Income
|
Sanara Medtech Inc
Operating Income Peer Comparison
Comparables:
HAE
COO
XRAY
ALGN
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sanara Medtech Inc
NASDAQ:SMTI
|
Operating Income
-$4.2m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
-4%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Operating Income
$199.3m
|
CAGR 3-Years
24%
|
CAGR 5-Years
13%
|
CAGR 10-Years
4%
|
|
|
Cooper Companies Inc
NYSE:COO
|
Operating Income
$536.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Operating Income
$296m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Operating Income
$656.7m
|
CAGR 3-Years
19%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
See Also
What is Sanara Medtech Inc's Operating Income?
Operating Income
-4.2m
USD
-4.2m
USD
Based on the financial report for Dec 31, 2023, Sanara Medtech Inc's Operating Income amounts to -4.2m USD.
What is Sanara Medtech Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-4%
-4%
Over the last year, the Operating Income growth was 65%. The average annual Operating Income growth rates for Sanara Medtech Inc have been 6% over the past three years , -53% over the past five years , and -4% over the past ten years .
You don't have any saved screeners yet
